Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 13 | 2017 | 3279 | 1.200 |
Why?
|
| Motor Activity | 4 | 2014 | 328 | 0.760 |
Why?
|
| Cartoons as Topic | 1 | 2014 | 3 | 0.410 |
Why?
|
| Body Mass Index | 4 | 2013 | 867 | 0.400 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2013 | 52 | 0.390 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 27 | 0.390 |
Why?
|
| Health Education | 1 | 2014 | 109 | 0.390 |
Why?
|
| Health Promotion | 2 | 2014 | 176 | 0.370 |
Why?
|
| Reproductive Physiological Phenomena | 1 | 2012 | 4 | 0.370 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 262 | 0.370 |
Why?
|
| Lactation | 1 | 2012 | 57 | 0.360 |
Why?
|
| Walking | 2 | 2010 | 113 | 0.360 |
Why?
|
| Breast | 1 | 2013 | 315 | 0.340 |
Why?
|
| Gasoline | 1 | 2011 | 3 | 0.340 |
Why?
|
| Breast Feeding | 1 | 2012 | 113 | 0.330 |
Why?
|
| Feeding Behavior | 1 | 2014 | 352 | 0.330 |
Why?
|
| Environment Design | 1 | 2010 | 12 | 0.320 |
Why?
|
| Diabetes Complications | 1 | 2012 | 176 | 0.320 |
Why?
|
| Bicycling | 1 | 2010 | 21 | 0.320 |
Why?
|
| Running | 1 | 2010 | 30 | 0.320 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 1090 | 0.310 |
Why?
|
| Mastectomy | 3 | 2017 | 272 | 0.300 |
Why?
|
| Residence Characteristics | 1 | 2010 | 228 | 0.280 |
Why?
|
| Risk Factors | 7 | 2014 | 6269 | 0.240 |
Why?
|
| Female | 22 | 2017 | 51685 | 0.220 |
Why?
|
| United States | 9 | 2017 | 8252 | 0.220 |
Why?
|
| Case-Control Studies | 3 | 2014 | 2002 | 0.210 |
Why?
|
| Longitudinal Studies | 4 | 2013 | 1295 | 0.210 |
Why?
|
| Logistic Models | 4 | 2017 | 1275 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1290 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2569 | 0.180 |
Why?
|
| Young Adult | 7 | 2015 | 7556 | 0.180 |
Why?
|
| Adult | 14 | 2015 | 29548 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2013 | 726 | 0.170 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2017 | 325 | 0.170 |
Why?
|
| Humans | 23 | 2017 | 98223 | 0.170 |
Why?
|
| Body Weight | 3 | 2013 | 456 | 0.170 |
Why?
|
| Surveys and Questionnaires | 5 | 2014 | 3030 | 0.160 |
Why?
|
| Middle Aged | 10 | 2017 | 29494 | 0.130 |
Why?
|
| Adolescent | 8 | 2015 | 10127 | 0.130 |
Why?
|
| Receptors, Progesterone | 2 | 2017 | 208 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 160 | 0.120 |
Why?
|
| Nigeria | 2 | 2013 | 174 | 0.120 |
Why?
|
| Aged | 7 | 2017 | 21824 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2017 | 250 | 0.110 |
Why?
|
| Overweight | 2 | 2006 | 128 | 0.110 |
Why?
|
| Africa | 1 | 2014 | 113 | 0.100 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 84 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2013 | 4815 | 0.100 |
Why?
|
| Literature | 1 | 2014 | 2 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2017 | 394 | 0.100 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 238 | 0.100 |
Why?
|
| New York City | 1 | 2014 | 75 | 0.100 |
Why?
|
| Vegetables | 1 | 2014 | 50 | 0.100 |
Why?
|
| Life Style | 1 | 2015 | 193 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 166 | 0.100 |
Why?
|
| Fruit | 1 | 2014 | 82 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2015 | 99 | 0.100 |
Why?
|
| Premenopause | 1 | 2013 | 65 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2015 | 184 | 0.100 |
Why?
|
| Parity | 1 | 2013 | 97 | 0.100 |
Why?
|
| Postmenopause | 1 | 2013 | 109 | 0.100 |
Why?
|
| Indians, North American | 1 | 2013 | 49 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 159 | 0.090 |
Why?
|
| Tanzania | 1 | 2012 | 49 | 0.090 |
Why?
|
| Age Distribution | 1 | 2013 | 212 | 0.090 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2012 | 12 | 0.090 |
Why?
|
| Carcinoma | 1 | 2015 | 442 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2013 | 169 | 0.090 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 244 | 0.090 |
Why?
|
| SEER Program | 1 | 2013 | 247 | 0.090 |
Why?
|
| Students | 1 | 2014 | 197 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2014 | 301 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2015 | 560 | 0.080 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 178 | 0.080 |
Why?
|
| Registries | 2 | 2014 | 1127 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 222 | 0.080 |
Why?
|
| Obesity | 2 | 2008 | 1076 | 0.080 |
Why?
|
| Survivors | 1 | 2011 | 211 | 0.080 |
Why?
|
| Social Class | 1 | 2011 | 156 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 7409 | 0.080 |
Why?
|
| Mammography | 1 | 2013 | 504 | 0.080 |
Why?
|
| Male | 9 | 2014 | 47195 | 0.070 |
Why?
|
| Urban Population | 1 | 2010 | 249 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 402 | 0.070 |
Why?
|
| Energy Intake | 1 | 2008 | 100 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 4041 | 0.070 |
Why?
|
| Incidence | 1 | 2013 | 1786 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 554 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 138 | 0.070 |
Why?
|
| Prognosis | 2 | 2015 | 4126 | 0.060 |
Why?
|
| Child | 4 | 2014 | 7730 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2014 | 851 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 830 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1539 | 0.060 |
Why?
|
| Age Factors | 4 | 2017 | 1972 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 2085 | 0.060 |
Why?
|
| Pregnancy | 1 | 2013 | 3266 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2013 | 2598 | 0.060 |
Why?
|
| Body Composition | 1 | 2005 | 88 | 0.050 |
Why?
|
| Child Behavior | 1 | 2005 | 51 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2005 | 118 | 0.050 |
Why?
|
| Health Behavior | 1 | 2005 | 202 | 0.050 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 2054 | 0.050 |
Why?
|
| Exercise | 1 | 2005 | 382 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 3217 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2017 | 115 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 3348 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 525 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 430 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1009 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 26 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 921 | 0.030 |
Why?
|
| Sacroiliitis | 1 | 2014 | 4 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 426 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 2014 | 24 | 0.030 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2014 | 30 | 0.030 |
Why?
|
| Arthralgia | 1 | 2014 | 44 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 520 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 131 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 583 | 0.020 |
Why?
|
| Barbados | 1 | 2012 | 7 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 1097 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 420 | 0.020 |
Why?
|
| Guam | 1 | 2011 | 1 | 0.020 |
Why?
|
| West Indies | 1 | 2011 | 4 | 0.020 |
Why?
|
| Sex Factors | 2 | 2005 | 1142 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2017 | 11031 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1751 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 551 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 310 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 2050 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 219 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1224 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1114 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 118 | 0.020 |
Why?
|
| Self Report | 1 | 2011 | 357 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 1519 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2008 | 10 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 666 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 44 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 2222 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 2894 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2012 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 205 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 1891 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2653 | 0.020 |
Why?
|
| Russia | 1 | 2006 | 29 | 0.020 |
Why?
|
| Brazil | 1 | 2006 | 93 | 0.020 |
Why?
|
| Australia | 1 | 2006 | 126 | 0.020 |
Why?
|
| United Kingdom | 1 | 2006 | 211 | 0.010 |
Why?
|
| China | 1 | 2006 | 277 | 0.010 |
Why?
|
| Health Surveys | 1 | 2006 | 254 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 301 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 676 | 0.010 |
Why?
|
| Rural Population | 1 | 2005 | 193 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 265 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 1107 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1391 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1841 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 2789 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 5573 | 0.010 |
Why?
|